Loading
₹887.05
−3.30−0.37%today
Market closed · 7 Oct, 3:30 pm
+14.13%over 1 year
Today's range
₹881.30₹892.90
52-week range
₹579.15₹977.55
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 2,124 | 592 | 27.9% | 10.43 |
| FY25 | 1,845 | 451 | 24.5% | 8.04 |
| FY24 | 1,419 | 367 | 25.9% | 6.54 |
| FY23 | 1,057 | 385 | 36.4% | 6.86 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 71.42% | 74.68% | 74.69% | 74.69% |
| FIIs | 2.58% | 1.28% | 1.36% | 1.67% |
| DIIs | 13.48% | 11.55% | 7.60% | 7.22% |
| of which mutual funds | 11.15% | 10.12% | 6.89% | 6.68% |
| Government | n/a | n/a | 0.00% | n/a |
| Public | 12.53% | 12.50% | 16.35% | 16.42% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Biocon Ltd.BIOCON | 360.00 | −2.47% | 58,669 |
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
| Anthem Biosciences Ltd.ANTHEM · this stock | 887.05 | −0.37% | 49,988 |
| Ipca Laboratories Ltd.IPCALAB | 1,929.00 | −0.85% | 48,940 |
| Ajanta Pharmaceuticals Ltd.AJANTPHARM | 3,570.00 | −0.10% | 44,610 |
| Glaxosmithkline Pharmaceuticals Ltd.GLAXO | 2,628.00 | −4.61% | 44,520 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.